Stock Report

All about this stock under one free report Last Updated: 14-May-2026

Stock Rating

See the stock’s health at a glance, before it's too late.

Wealth Insight New Issue

Serious stock insights. No fluff. No FOMO.

Recently Viewed

Clear All

Evoke Pharma Inc. (EVOK)

Stock Card factsheet share-fund-plan-icon

$11.00

$0.00 (0.00%)

As on 17-Dec-2025 09:30EDT

Market cap

info icon

$19 Mln

Revenue (TTM)

info icon

$14 Mln

P/E Ratio

info icon

--

P/B Ratio

info icon

5.6

Div. Yield

info icon

0 %

Evoke Pharma (EVOK) Share Price

Compare

High:loading Low:loading Return: loading

Max:loading Min:loading Median:loading

Max:loading Min:loading Median:loading

Price P/E Ratio P/B Ratio

Stock Range

Today’s Range

Low: 11.00 High: 11.00

52 Week Range

Low: 1.94 High: 32.50

Liquidityliquidity Low

Low Moderate High

Fundamentals

  • Net Profit (TTM)Net Profit (TTM) information

    $0 Mln

  • ROEROE information

    -1.3 %

  • ROCEROCE information

    -- %

  • Industry P/EIndustry P/E information

    26.75

  • EV/EBITDAEV/EBITDA information

    -0.4

  • Debt to EquityDebt to Equity information

    0

  • Book ValueBook Value information

    $--

  • EPSEPS information

    $-2.4

  • Face valueFace value information

    --

  • Shares outstandingShares outstanding information

    1,722,409

10 Years Aggregate

CFO

$-82.73 Mln

EBITDA

$-97.96 Mln

Net Profit

$-101.26 Mln

Performance

Company
YTD
1 Month
3 Months
1 Year
3 Years
5 Years
10 Years
Evoke Pharma (EVOK)
148.9 2.9 112.4 139.7 -21.6 -51.0 -31.5
BSE Sensex*
-11.5 -2.5 -9.3 -7.7 6.5 9.0 11.4
S&P Small-Cap 600#
-5.8 -5.3 -13.7 -6.3 5.3 3.0 5.5
As on 17-Dec-2025  |  *As on 14-May-2026  |  #As on 26-Oct-2023
Company
2025
2024
2023
2021
2020
2019
Evoke Pharma (EVOK)
402.3 -64.6 -60.8 -78.7 59.3 -34.7
S&P Small-Cap 600
4.0 7.0 13.9 25.3 9.6 20.9
BSE Sensex
9.1 8.1 18.7 22.0 15.8 14.4

Essential Checks

View Details

Is there a threat to the company's solvency?

Can creative accounting be detected through the financial numbers?

How did the company perform in the last one year?

Financials

View Details
Quarterly Annual

*All values are in ($ Mln)

Annual

*All values are in ($ Mln)

Annual

*All values are in ($ Mln)

Key Ratios

View Details

5Y Avg -- 3Y Avg -- TTM --

P/E Ratio

--

--Min --Median --Max

P/B Ratio

--

--Min --Median --Max

Earnings Yield (%)

--

Earnings Yield (%) = EBIT / Enterprise value

PEG Ratio

--

Price = Price / Earnings to growth ratio

Shareholding Pattern

View Details
These are advertorial stories which keeps Value Research free for all. Click here to mark your interest for an ad-free experience in a paid plan

About Evoke Pharma (EVOK)

Evoke Pharma, Inc. operates as a specialty pharmaceutical company that focuses on the development and commercialization of drugs for the treatment of gastroenterological disorders and diseases. It offers Gimoti, a metoclopramide nasal spray to treat...  symptoms associated with acute and recurrent diabetic gastroparesis in adults. The company markets its products to gastroenterologists, internal medicine specialists, primary care physicians, and select health care providers. Evoke Pharma, Inc. was incorporated in 2007 and is based in Solana Beach, California. As of December 15, 2025, Evoke Pharma, Inc. operates as a subsidiary of QOL Medical, LLC.  Read more

  • Co-Founder, President, CEO, COO, Secretary, Treasurer & Director

    Mr. Matthew J. D'Onofrio MBA

  • Co-Founder, President, CEO, COO, Secretary, Treasurer & Director

    Mr. Matthew J. D'Onofrio MBA

  • Headquarters

    Solana Beach, CA

  • Website

    https://www.evokepharma.com

Value Research Ratings

Our rating system has guided millions of investors in the past 20 years.

Top Rated Stocks

All stocks with 5-star Value Research Ratings

Top Rated Stocks Icon

High Quality Small Caps

Small-cap stocks rated high on quality score

High Quality Small Caps Icon

High Growth Large Caps

Large-cap stocks with a high growth score

High Growth Large Caps Icon

Value Meets Momentum

Top momentum stocks with a high valuation score

Value Meets Momentum Icon

Top Rated Banks

Banks that rate high on Value Research Stock Ratings

Top Rated Banks Icon
Explore Screeners
Edit peer-selector-edit

FAQs for Evoke Pharma (EVOK)

The share price of Evoke Pharma Inc (EVOK) is $11.00 (NASDAQ) as of 17-Dec-2025 09:30 EDT. Evoke Pharma Inc (EVOK) has given a return of -21.57% in the last 3 years.

Since, TTM earnings of Evoke Pharma Inc (EVOK) is negative, P/E ratio is not available.
The P/B ratio of Evoke Pharma Inc (EVOK) is 5.64 times as on 02-Mar-2026, a 1 discount to its peers’ median range of 5.71 times.


PE & PB ratio at the end of financial year.


Year P/E Ratio P/B Ratio
2024
-1.23
0.93
2023
-0.45
-1.36
2022
-0.09
0.18
2021
-0.01
0.04
2020
-0.04
-0.15

The 52-week high and low of Evoke Pharma Inc (EVOK) are Rs 32.50 and Rs 1.94 as of 14-May-2026.

Evoke Pharma Inc (EVOK) has a market capitalisation of $ 19 Mln as on 02-Mar-2026. As per SEBI classification, it is a Small Cap company.

Before investing in Evoke Pharma Inc (EVOK), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.

For guidance, explore our expert-curated portfolios and Stock recommendations with Value Research Stock Advisor.
Want to explore on your own? Click here to see how this stock scores on quality, growth, valuation, and momentum.